基于AI从人群规模单细胞数据刻画阿尔茨海默病表型
AI-based characterization of Alzheimer's disease phenotypes from population-scale single-cell data
阿尔茨海默病临床表现多样,其病因仍不清楚。PsychAD项目生成覆盖1000多例脑、超600万个细胞核的前额叶单核RNA测序数据,作者据此开发计算框架PASCode,用图神经网络整合多种统计方法对单细胞与表型的关联打分。他们从584名有AD相关表型的供者中识别出约150万个表型相关细胞,在27个脑细胞亚类中优先锁定与小胶质细胞、反应性星形胶质细胞、兴奋/抑制失衡和线粒体功能障碍相关的亚群与基因。研究还在外部数据中验证并开放了工具与预训练模型,为精准诊疗提供线索。
为什么推荐给您:结合大规模单细胞数据与AI框架识别AD表型相关细胞,属值得关注的新方法。
不需要生物学背景,多打比方
正在获取全文并生成讲解(拿不到全文就依据摘要),大约需要 30–60 秒…
已等待 0 秒
这篇还没有动画
动画会把研究的流程、作用机制和关键结果一步一步演示出来,每一步都标明出自原文哪里。制作大约需要 30–60 秒。
摘要Abstract
The complexity of Alzheimer's disease (AD) manifests in diverse clinical phenotypes, including cognitive impairment and neuropsychiatric symptoms. However, the etiology of these phenotypes remains elusive. To address this, the PsychAD project generated a population-level single-nucleus RNA sequencing dataset comprising over 6 million nuclei from the prefrontal cortex of >1,000 individual brains, covering a variety of disease phenotypes. Here, leveraging this dataset, we developed a computational framework, called Phenotype Associated Single Cell encoder (PASCode), to score single-cell phenotype associations, and identified ∼1.5 million phenotype-associated cells (PACs) from 584 donors with AD-related phenotypes. PASCode ensembles multiple statistical methods into a graph neural model for robust scoring. Comparing PACs within 27 brain cell subclasses, we prioritized cell subpopulations and their expressed genes for various AD phenotypes. For instance, we identified microglia subpopulations implicated in AD pathology; reactive astrocyte subtypes with altered neuroprotective and neurotoxic gene expression that likely confer cognitive resilience; and enhanced excitatory/inhibitory imbalance and mitochondrial dysfunction in cognitively impaired AD donors. We also identified many PACs for multiple phenotypes, including the astrocytes between AD and depression showing specific gene expression patterns such as inflammation and endoplasmic reticulum stress pathways. These prioritized subpopulations, genes and pathways potentially offer valuable insights for precision diagnostic and therapeutic development. We also validated our findings in external population-scale datasets including AD and major depressive disorder, compiled an AD-phenotypic single-cell atlas and delivered the framework as an open-source tool with pre-trained models and a web application for community use.